Keyword Analysis & Research: ertapenem pseudomonas

uptodate.com

https://www.uptodate.com/contents/principles-of-antimicrobial-therapy-of-pseudomonas-aeruginosa-infections

WEBFeb 6, 2024 · This organism is important because it is often antibiotic resistant and can cause severe hospital-acquired infections associated with a high mortality rate, especially in immunocompromised hosts. The principles of antimicrobial treatment of infections caused by P. aeruginosa will be reviewed here.

DA: 7 PA: 61 MOZ Rank: 15

idsociety.org

https://www.idsociety.org/practice-guideline/amr-guidance/

WEBThis guidance document provides recommendations to clinicians for treatment of infections caused by extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and difficult-to-treat Pseudomonas aeruginosa (DTR-P. aeruginosa).

DA: 36 PA: 78 MOZ Rank: 65

wikipedia.org

https://en.wikipedia.org/wiki/Ertapenem

WEBSimilar to doripenem, meropenem and biapenem, ertapenem has slightly better activity against many Gram-negative bacteria than other carbapenems such as imipenem. In contrast to imipenem, doripenem and meropenem, it is not active against Enterococcus, Pseudomonas and Acinetobacter species.

DA: 48 PA: 98 MOZ Rank: 72

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670755/

WEBNov 6, 2020 · Ertapenem is a carbapenem with weak activity against Pseudomonas spp. and Acinetobacter spp. 1 . In randomized controlled trials, ertapenem has been used for severe community-acquired infections and is licensed for intra-abdominal infections, community-acquired pneumonia, skin and soft tissue infections, and complicated urinary …

DA: 14 PA: 56 MOZ Rank: 74

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6535521/

WEBMay 23, 2019 · This peptide antimicrobial is primarily active against P. aeruginosa and has no significant effect against other tested species, including other Pseudomonas species, with the exception of Pseudomonas stutzeri and Pseudomonas mendocina ( 9 ).

DA: 94 PA: 58 MOZ Rank: 56

nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872158/

WEBDec 21, 2017 · It occurs mainly among Gram-negative pathogens such as Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumannii, and may be intrinsic or mediated by transferable carbapenemase-encoding genes.

DA: 52 PA: 90 MOZ Rank: 13

nih.gov

https://pubmed.ncbi.nlm.nih.gov/22047702/

WEBResults from ten clinical studies evaluating the effect of ertapenem use on the susceptibility of Pseudomonas to carbapenems have uniformly shown that ertapenem use does not result in decreased Pseudomonas susceptibility to these antipseudomonal carbapenems.

DA: 80 PA: 5 MOZ Rank: 21

drugs.com

https://www.drugs.com/mtm/ertapenem.html

WEBAug 21, 2023 · Ertapenem is an antibiotic that is used to treat severe infections caused by bacteria in the skin, lungs, stomach, pelvis, and urinary tract. Ertapenem is also used to prevent infection in people having certain types of surgery. Ertapenem may also be used for purposes not listed in this medication guide. Ertapenem side effects.

DA: 4 PA: 76 MOZ Rank: 8

medlineplus.gov

https://medlineplus.gov/druginfo/meds/a614001.html

WEBErtapenem injection is used to treat certain serious infections, including pneumonia and urinary tract, skin, diabetic foot, gynecological, pelvic, and abdominal (stomach area) infections, that are caused by bacteria. It is also used for the prevention of infections following colorectal surgery. pseudomonas

pseudomonas

DA: 42 PA: 11 MOZ Rank: 76

oup.com

https://academic.oup.com/jac/article/55/3/306/758347

WEBMar 1, 2005 · Ertapenem is a new carbapenem, differing from imipenem and meropenem in having only weak activity against Pseudomonas and Acinetobacter spp. and in requiring only once-daily administration. 1 It is marketed for use in severe community-acquired infections, where non-fermenters are unlikely, and is licensed for intra-abdominal …

DA: 56 PA: 63 MOZ Rank: 60